Nosa Plugs AB (“Nosa Plugs” or “the Company”) announced on March 24, 2025, that the Company is launc...
Redeye provides some additional comments and makes positive valuation changes following GomSpace's c...
Redeye has found that InfraCom has purchased the bankruptcy estate of Koneo, a IT Service company wi...
Pharma Equity Group (“PEG” or “the Company”) has recently refined the Company’s execution strategy, ...
Redeye returns with an update following Paxman’s takeover offer to Dignitana and the directed share ...
In the Asian region Vitrolife faces a challenging period.
Redeye provides a comment on Scandinavian ChemoTech's recently announced collaboration with a global...
EMB Mission Bound (”EMB” eller ”Bolaget”), f.d. Embark Group, har publicerat bolagets delårsrapport ...
Obducat genomför en företrädesemission 20 mars - 3 april om 50 MSEK till teckningskurs 0,75 SEK, vil...
Acquiring consulting company BlakYaks at 10.7x EV/EBITA Seems to be a good growing and highly profit...
Redeye comments on Paxman’s directed issue to institutional investors, raising SEK123.
Pharma Equity Group (“PEG” or “the Company”) published its Year-End report for 2024 on the 20th of M...
Redeye comments on the positive phase I data from the study conducted by Leaderna in China.
Redeye comments on the clinical data from the SESAR study and the confusion it brought.
Luxbright AB (”Luxbright” eller ”Bolaget”) meddelade den 19 mars 2025 att Bolaget har erhållit ytter...
Redeye comments on the reverse split and new conditions of TO12.
This morning GomSpace announced a directed share issue of SEK200m to its largest shareholder the Har...
Q-linea’s recent progress in extending the commercial network, establishing a pipeline of ASTar eval...
Redsense avslutar 2024 starkt med sitt första helår av vinst.
EBITA margin above 6% No more than 1.5x Net debt/EBITDA RTM Dividend at ~30% of net profit Ambitiou...